Existence of advanced glycation / lipoxidation end-products in parenteral nutrition solutions and effects of infusion conditions on their levels
Keywords:
Degradation products;, Parenteral nutrition solution;, Advanced glycation end-products;, N-carboxymethyl lysine;, 4-hydroxynonenalAbstract
Infusion solutions must be stable from the production stage until the infusion stage. Some infusion fluids contain degradation products, known as advanced glycation end products (AGEs); however, it is unknown whether AGEs exist in parenteral nutrition solutions. We aimed to investigate this question and test the effect of infusion conditions on AGE formation in parenteral nutrition solution. Nine parenteral nutrition solutions were supplied by the pharmacy with which we collaborated. To simulate the infusion conditions, the solutions were held in a patient room with standard lighting and temperature for 24 hours. Samples were taken at the beginning (group A) and the end (24th hour, group B) of the infusion period. The degradation products were 3-deoxyglucosone, pentosidine, N-carboxymethyl lysine, and 4-hydroxynonenal, which we investigated by high-performance liquid chromatography-mass spectrometry (LC-MS) and Q-TOF LC/MS methods. Two of four degradation products, 4-hydroxynonenal and N-carboxymethyl lysine, were detected in all samples, and Group B had higher levels of both compounds compared to Group A, who showed that the quantities of these compounds increased in room conditions over time. The increase was significant for 4-hydroxynonenal (p=0.03), but not for N-carboxymethyl lysine (p=0.23). Moreover, we detected in the parenteral nutrition solutions a compound that could have been 4-hydroxy-2-butynal or furanone.
Downloads
References
Ajith TA, Vinodkumar P. Advanced glycation end products: Association with the pathogenesis of diseases and the current therapeutic advances. Curr Clin Pharmacol. 2016;11(2):118-27.
Allwood MC, Kearney MC. Compatibility and stability of additives in parenteral nutrition admixtures. Nutrition. 1998;14(9):697-706.
Allwood MC, Martin HJ. The photodegradation of vitamins A and E in parenteral nutrition mixtures during infusion. Clin Nutr. 2000;19(5):339-42.
Bryland A, Broman M, Erixon M, Klarin B, Lindén T, Friberg H, et al. Infusion fluids contain harmful glucose degradation products. Intensive Care Med. 2010;36(7):1213-20.
Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, et al. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int. 2008;28(2):174-82.
Christaki E, Lazaridis N, Opal SM. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis? Curr Opin Infect Dis. 2012;25(3):304-11.
Driscoll DF, Silvestri AP, Bistrian BR, Mikrut BA. Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging. Am J Health Syst Pharm. 2007;64(4):396-403.
Gonyon T, Tomaso AE Jr, Kotha P, Owen H, Patel D, Carter PW, et al. Interactions between parenteral lipid emulsions and container surfaces. PDA J Pharm Sci Technol. 2013;67(3):247-54.
Guéraud F. 4-Hydroxynonenal metabolites and adducts in pre-carcinogenic conditions and cancer. Free Radic Biol Med. 2017;111:196-208.
Henning C, Glomb MA. Pathways of the Maillard reaction under physiological conditions. Glycoconj J. 2016;33(4):499-512.
Hoff DS, Michaelson AS. Effects of light exposure on total parenteral nutrition and its implications in the neonatal population. J Pediatr Pharmacol Ther. 2009;14(3):132-43.
Jalabert A, Grand A, Steghens JP, Barbotte E, Pigue C, Picaud JC. Lipid peroxidation in all-in-one admixtures for preterm neonates: impact of amount of lipid, type of lipid emulsion and delivery condition. Acta Paediatr. 2011;100(9):1200-05.
Kambia N, Dine T, Gressier B, Luyckx M, Brunet C, Guimber D, et al. Strong variability of di(2-ethylhexyl) phthalate (DEHP) plasmatic rate in infants and children undergoing 12-hour cyclic parenteral nutrition. JPEN J Parenter Enteral Nutr. 2013;37(2):229-35.
Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int . 2013;33(3):242-51.
Meertens JH, Nienhuis HL, Lefrandt JD, Schalkwijk CG, Nyyssönen K, Ligtenberg JJ, et al. The course of skin and serum biomarkers of advanced glycation endproducts and its association with oxidative stress, inflammation, disease severity, and mortality during ICU admission in critically ill patients: results from a prospective pilot study. PLoS One. 2016;11(8):e0160893.
Mihaleva VV, Vorst O, Maliepaard C, Verhoeven HA, de Vos RCH, Hall RD, et al. Accurate mass error correction in liquid chromatography time-of-flight mass spectrometry-based metabolomics. Metabolomics. 2008;4(2):171-82.
Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013;60:10-37.
Schröter A, Mahler HC, Sayed NB, Koulov AV, Huwyler J, Jahn M. 4-Hydroxynonenal - A toxic leachable from clinically used administration materials. J Pharm Sci. 2021;110(9):3268-75.
Shoeb M, Ansari NH, Srivastava SK, Ramana KV. 4-Hydroxynonenal in the pathogenesis and progression of human diseases. Curr Med Chem. 2014;21(2):230-7.
Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78(3):779-87.
Steger PJ, Mühlebach SF. In vitro oxidation of I.V. lipid emulsions in different all-in-one admixture bags assessed by an iodometric assay and gas-liquid chromatography. Nutrition. 1997;13(2):133-40.
Timucin AC, Basaga H. Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2. Free RadicBiol Med. 2017;111:209-18.
Thomovsky EJ, Backus RC, Mann FA, Richmond CK, Wagner-Mann CC. Effects of temperature and handling conditions on lipid emulsion stability in veterinary parenteral nutrition admixtures during simulated intravenous administration. Am J Vet Res. 2008;69(5):652-8.
Tovsen ML, Smistad G, Bjerke TM, Tønnesen HH, Kristensen S. Physicochemical Stability of Emulsions and Admixtures for Parenteral Nutrition during Irradiation by Glass-Filtered Daylight at Standardized Conditions. PDA J Pharm Sci Technol . 2015;69(3):346-54.
Turmezei J, Jávorszky E, Szabó E, Dredán J, Kállai-Szabó B, Zelkó R. Effect of storage temperature on the stability of total parenteral nutrition admixtures prepared for infants. Acta Pol Pharm. 2015;72(5):843-9.
Watanabe M, Toyomura T, Tomiyama M, Wake H, Liu K, Teshigawara K, et al. Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions. Mol Biol Rep. 2020;47(9):7153-9.
Yang J, Zhang F, Shi H, Gao Y, Dong Z, Ma L, et al. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/ reperfusion injury. FASEB J. 2019;33(12):14410-22.
Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, et al. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem. 2003;278(42):41380-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
How to Cite
Funding data
-
Abant Izzet Baysal Üniversitesi
Grant numbers [grant no: 140814.721].
